1 results match your criteria: "Campus Police General Hospital[Affiliation]"
Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease.
Pak J Med Sci
January 2016
Dr. Lubna Akhtar, FCPS Gynae & Obs, Department of Pharmacology, Sheikh Zayed Medical College, Campus Police General Hospital, Jail Chowk, Rahim Yar Khan, Pakistan.
Objective: To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia.
Methods: A randomized placebo controlled trial was conducted at outpatient clinic of Medical Unit-I of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which fifty eight patients of NAFLD with dyslipidemia were divided in to two, case and control groups. The case group was given tablet Vildagliptin 50mg twice a day for twelve weeks and control group was given placebo in same way.